3D Printing in Medical Devices Market by Product Type, Technology, Component, End User

Description

List of Tables

[187 Pages Report] The 3D Printing in Medical Devices Market size was estimated at USD 7.09 billion in 2023 and expected to reach USD 8.69 billion in 2024, at a CAGR 22.99% to reach USD 30.19 billion by 2030.

Various 3D printing technologies have emerged in the medical device industry, offering innovative solutions for orthopedic implants, surgical instruments, and patient-specific models. The significant advantage of 3D printing is its ability to manufacture highly-customized devices tailored to individual patient's anatomy and requirements. 3D-printed cranial implants can be designed based on precise measurements from scans or MRI images, ensuring an accurate fit while minimizing complications during surgery. Patient-specific guides help surgeons accurately plan and execute complex procedures, such as joint replacement surgeries, with greater precision. In recent years, 3D printing has emerged as a driving force for innovation in medical devices owing to its inherent benefits in customization and rapid prototyping. There is an increasing trend toward using this technology for personalized medicine and patient-specific prosthetics, orthopedic implants, dental appliances, and surgical instruments. These applications have been facilitated by advancements in biocompatible materials such as metals, polymers, ceramics, and even biological substances, such as hydrogels, for tissue engineering. Despite its numerous benefits, the widespread adoption of 3D printing in medical devices faces challenges owing to higher costs associated with the 3D printed medical devices, and a lack of expertise to operate these devices act as a restraining factor. Moreover, ongoing R&D efforts by market companies to advance 3D printing materials for medical purposes are expected to revolutionize 3D printing in the medical device industry.

KEY MARKET STATISTICS
Base Year [2023]	USD 7.09 billion
Estimated Year [2024]	USD 8.69 billion
Forecast Year [2030]	USD 30.19 billion
CAGR (%)	22.99%

Product Type: Increasing demand for prosthetics & implants for increased satisfaction with medical treatments

Bone & cartilage scaffolds are biocompatible and biodegradable structures that support the growth and regeneration of bone and cartilage tissues, which mimic the natural extracellular matrix while providing mechanical strength, thereby promoting tissue repair and regeneration. Ligament & tendon scaffolds are similar to bone scaffolds, which are designed to assist in the regeneration of ligaments and tendons by providing a temporary framework for cells to grow on. 3D printing technology can create customized implants and prosthetics specifically tailored to individual patient needs, allowing for more precise fitting, better functionality, and improved comfort compared to traditional manufacturing methods. Moreover, standard implants are mass-produced, off-the-shelf solutions for common medical conditions such as joint replacements. Surgical guides are patient-specific tools that help surgeons plan and execute complex surgical procedures accurately. Surgical guides can be precisely tailored to each individual's anatomy using 3D printing technology. Craniomaxillofacial guides assist surgeons in reconstructive surgeries of the skull and facial bones by providing accurate templates for bone cutting, positioning, and fixation.

Moreover, dental guides are used in dental procedures, such as implant placement or orthodontic treatments, to ensure proper positioning and alignment of dental components. Orthopedic guides are designed to assist in the accurate alignment of orthopedic implants during joint replacement surgeries that allow for precise preparation of the bone surface, ensuring optimal contact between the implant and natural bone structure for improved stability and longevity. The surgical instruments in 3D printing technology have been used to create various surgical instruments such as retractors, scalpels, and forceps. 3D-printed retractors can be customized to suit individual patient anatomies or specific procedural requirements. The production of 3D printed scalpels allows for modifications in blade design that can enhance cutting efficiency or reduce tissue damage during surgery. Furthermore, 3D printed surgical fasteners such as clips or staples can be designed to provide optimal strength, flexibility, and biocompatibility. Additionally, combining 3D printing with tissue engineering techniques has allowed the creation of bioengineered constructs containing living cells, which hold significant potential for regenerative medicine applications, including developing functional organs or tissues for transplantation.

Technology: Rising adoption of photopolymerization technology for manufacturing microscale devices

Droplet deposition/extrusion-based technologies involve depositing small droplets or continuous filaments of material to create 3D structures. Extrusion-based methods are ideal for bioprinting and fabricating complex medical devices owing to their versatility in handling various materials, such as hydrogels, polymers, and composites. Fused deposition modeling (FDM) is an extrusion-based process that utilizes thermoplastic materials to build objects layer by layer. It has gained popularity in the medical field for creating low-cost anatomical models used in surgical planning, patient education, and prosthetics manufacturing. Low-temperature deposition manufacturing (LDM) uses a low-temperature extrusion process to deposit layers of material, significantly reducing thermal stress on sensitive biomaterials and making it suitable for tissue engineering and drug delivery systems. Multiphase jet solidification (MJS) is an inkjet-like technology that solidifies liquid droplets upon contact with a cooling substrate, which enables the creation of highly complex structures with intricate features ideal for implantable devices and microfluidic components. Electron beam melting (EBM) is a powder bed fusion technique that uses a high-energy electron beam to selectively fuse metal particles layer by layer. EBM has been employed for producing customized implants made from metals, such as titanium, offering superior mechanical properties and biocompatibility. Laser beam melting (LBM) is another powder bed fusion method wherein a focused laser beam selectively melts powder particles. LBM excels at producing high-quality metal parts, such as dental prosthetics and orthopedic implants, with complex geometries and excellent mechanical properties. Direct metal laser sintering (DMLS) is a laser-based powder bed fusion technology that combines metal particles to create functional components. DMLS offers rapid production and customization as it is known for its ability to fabricate intricate medical devices, such as hearing aids and dental restorations. Selective laser melting (SLM) uses a high-power laser to fully melt metal powders into solid 3D structures. This technology has demonstrated great potential in producing complex implants with tailored mechanical properties and porous structures that promote tissue integration. Selective laser sintering (SLS) is a powder bed fusion process that employs a laser to sinter powdered materials without fully melting them. Widely used for creating plastic medical models, SLS can also produce biocompatible ceramic components for bone replacements or coatings on metallic implants. The photopolymerization technique involves hardening liquid photopolymer resins using ultraviolet light or other radiation sources. These offer high-resolution printing capabilities required for manufacturing microscale devices, such as microneedles for drug delivery systems. Digital light processing (DLP) is a vat polymerization method in which a digital projector selectively exposes photosensitive resin layers to ultraviolet light. DLP's speed and accuracy make it an attractive option for producing dental restorations, surgical guides, and hearing aids. PolyJet 3D printing technology is a jetting-based process that deposits precise droplets of photopolymers onto the build platform and cures them with ultraviolet light. This technology enables the simultaneous printing of multiple materials and colors, allowing for versatile medical devices, such as patient-specific anatomical models or multi-material implants. Stereolithography (SLA) is a vat polymerization method that uses ultraviolet lasers to trace patterns on the surface of a liquid photopolymer resin. SLA has been widely adopted in medical applications, such as dental models, surgical planning tools, and custom prosthetics, as one of the earliest 3D printing techniques. Two-photon polymerization (2PP) is an ultra-high-resolution technology based on multiphoton absorption processes that allow for fabricating intricate 3D microstructures in photosensitive.

Component: Growing utilization of various equipments based on material compatibility, and production speed

Innovative 3D printers have revolutionized medical device manufacturing by providing higher precision and enhanced flexibility in product design. Biocompatible materials play a crucial role in the creation of 3D-printed medical devices. Metals, such as titanium and stainless steel, provide high strength-to-weight ratios, making them ideal choices for orthopedic implants and surgical instruments. Additionally, polymers such as polyether ether ketone (PEEK) have emerged as a significant alternative owing to their lightweight nature and resistance to chemicals or wear. Continuous research is being conducted to discover newer materials with enhanced properties that could further optimize medical device manufacturing. Ceramic materials possess unique characteristics such as biocompatibility, high hardness, corrosion resistance, and low thermal conductivity, which make them suitable for several biomedical applications. Zirconia-based ceramics are widely used for dental crowns, while hydroxyapatite has proven effective as bone graft material.

Moreover, ongoing research focuses on developing biodegradable ceramic scaffolds for tissue regeneration and drug delivery systems. Although not a conventional choice in medical device production, paper has emerged as a versatile material for 3D printing low-cost medical devices. Resin materials in 3D printing offer high resolution and smooth surface finish, critical for producing accurate medical models and complex implants. In addition, photopolymer resins utilized in SLA or digital light processing (DLP) techniques have enabled the creation of finely detailed anatomical structures for surgical planning and education purposes.

Furthermore, biocompatible resins are gaining traction for their potential applications in temporary implants or drug delivery systems. Bespoke services and advanced software solutions have also become indispensable components of the 3D printing ecosystem within the medical field. Services, including rapid prototyping, on-demand manufacturing, and post-processing support, accelerate product development cycles while eliminating upfront investment costs. Moreover, advanced CAD/CAM software allows efficient design modification and simulation, ultimately improving patient outcomes.

End User: Wider application across the hospitals for better patient care and efficiently streamline clinical workflows

Academic institutions & research laboratories are at the forefront of advancing 3D printing technology in medical devices. These institutions actively engage in cutting-edge research, exploring novel applications and refining existing ones, collaborating with industry partners to develop prototypes and validate new device designs. Additionally, these institutions are responsible for training the next generation of professionals utilizing and advancing the field of 3D printing in medical devices. Furthermore, ambulatory surgical centers (ASCs) have embraced 3D printing technology to improve patient care by leveraging its potential to create custom-fit implants, prosthetics, and surgical instruments. ASCs need to streamline their operations as outpatient facilities for efficiency, cost-effectiveness, and better patient outcomes. Diagnostic centers primarily use 3D printing technology to create patient-specific anatomical models based on medical imaging data (such as CT or MRI). This technology has revolutionized diagnostic capabilities by producing physical representations of complex internal structures that can aid clinicians in better understanding specific conditions, planning treatment strategies, or educating patients about their health issues.

Moreover, recent advancements in bioprinting have led to the development of organ-on-a-chip platforms that can replicate human tissue responses, enabling researchers to study disease progression and test potential drug candidates more accurately. Hospitals have a pivotal role in adopting 3D printing in medical devices, utilizing this technology to offer better patient care and efficiently streamline clinical workflows. Custom 3D-printed implants and prosthetics have been widely adopted for their superior fit, resulting in better functional outcomes and reduced patient recovery times. Furthermore, 3D-printed surgical instruments and guides enable precision during surgeries, reducing complications and improving overall surgical outcomes.

Regional Insights

The Americas represents a highly developing landscape for 3D printing in the medical devices market due to the presence of strong healthcare infrastructure, rising R&D investments, and strict FDA regulations that encourage innovation in 3D printing. The favorable government initiatives and investments for introducing 3D printing in medical devices across Australia, India, and South Korea is benefiting the market growth in the Asia-Pacific. The massive presence of advanced technologies that assist in 3D printing with ongoing research and development (R&D) activities encourages the availability of novel 3D printing medical devices in the EMEA region. In Europe, EU countries have unified their regulations under the Medical Device Regulation (MDR), which mandates strict control over 3D-printed medical device manufacturing.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the 3D Printing in Medical Devices Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the 3D Printing in Medical Devices Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the 3D Printing in Medical Devices Market, highlighting leading vendors and their innovative profiles. These include 3D Systems Corporation, Abbott Laboratories, Anatomics Pty Ltd., Anisoprint SARL, Ansys, Inc., Apium Additive Technologies GmbH, Arkema SA, BICO Group, Biomedical Modeling Inc., Carbon, Inc., EOS GmbH, Evonik Industries AG, Formlabs Inc., GE HealthCare Technologies Inc., Henkel AG & Co. KGaA, Johnson & Johnson Services, Inc., Materialise NV, Organovo Holdings Inc., Prodways Group, Proto Labs, Inc., RapidMade Inc., Renishaw PLC, Restor3d, Inc., Siemens AG, SLM Solutions Group AG, Smith & Nephew PLC, Solvay S.A., Stratasys Ltd., Stryker Corporation, Thermo Fisher Scientific Inc., Zimmer Biomet Holdings, Inc., and Zortrax S.A..

Market Segmentation & Coverage

This research report categorizes the 3D Printing in Medical Devices Market to forecast the revenues and analyze trends in each of the following sub-markets:

Product Type
- Bone & Cartilage Scaffolds
- Ligament & Tendon Scaffolds
- Prosthetics & Implants
  - Custom Implants
  - Standard Implants

Surgical Guides
- Craniomaxillofacial Guides
- Dental Guides
- Orthopedic Guides

Surgical Instruments
- Retractors
- Scalpels
- Surgical Fasteners

Tissue Engineering Products

Technology
- Droplet Deposition/Extrusion-Based Technologies
  - Fused Deposition Modeling
  - Low-Temperature Deposition Manufacturing
  - Multiphase Jet Solidification

Electron Beam Melting
Laser Beam Melting
- Direct Metal Laser Sintering
- Selective Laser Melting
- Selective Laser Sintering

Photopolymerization
- Digital Light Processing
- Polyjet 3D Printing Technology
- Stereolithography
- Two-Photon Polymerization

Component
- Equipment
- Materials
  - Ceramics
  - Paper
  - Resin

Services & Software

End User
- Academic Institutions & Research Laboratories
- Ambulatory Surgical Centers
- Diagnostic Centers
- Hospitals

Region
- Americas
  - Argentina
  - Brazil
  - Canada
  - Mexico
  - United States
    - California
    - Florida
    - Illinois
    - New York
    - Ohio
    - Pennsylvania
    - Texas
- Asia-Pacific
  - Australia
  - China
  - India
  - Indonesia
  - Japan
  - Malaysia
  - Philippines
  - Singapore
  - South Korea
  - Taiwan
  - Thailand
  - Vietnam

Europe, Middle East & Africa
- Denmark
- Egypt
- Finland
- France
- Germany
- Israel
- Italy
- Netherlands
- Nigeria
- Norway
- Poland
- Qatar
- Russia
- Saudi Arabia
- South Africa
- Spain
- Sweden
- Switzerland
- Turkey
- United Arab Emirates
- United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the 3D Printing in Medical Devices Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the 3D Printing in Medical Devices Market?

3. What are the technology trends and regulatory frameworks in the 3D Printing in Medical Devices Market?

4. What is the market share of the leading vendors in the 3D Printing in Medical Devices Market?

5. Which modes and strategic moves are suitable for entering the 3D Printing in Medical Devices Market?

Product Code: MRR-430D3EB728CA

1. Preface

1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders

2. Research Methodology

2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

5.1. Market Dynamics
- 5.1.1. Drivers
  - 5.1.1.1. High demand for personalized or customized medical devices
  - 5.1.1.2. Awareness about 3D printing of medical devices provided by regulatory authorities
- 5.1.2. Restraints
  - 5.1.2.1. High cost and quality concerns of 3D printed medical device
- 5.1.3. Opportunities
  - 5.1.3.1. Advancements in printing materials and emergence of bioprinting
  - 5.1.3.2. Enhanced potential in point-of-care diagnostics manufacturing
- 5.1.4. Challenges
  - 5.1.4.1. Dearth of trained professionals for using 3D-printed medical device
5.2. Market Segmentation Analysis
- 5.2.1. Product Type: Increasing demand for prosthetics & implants for increased satisfaction with medical treatments
- 5.2.2. Technology: Rising adoption of photopolymerization technology for manufacturing microscale devices
- 5.2.3. Component: Growing utilization of various equipments based on material compatibility, and production speed
- 5.2.4. End User: Wider application across the hospitals for better patient care and efficiently streamline clinical workflows
5.3. Market Trend Analysis
- 5.3.1. Presence of native and established medical device market vendors offering innovative 3D printing technologies in the Americas
- 5.3.2. Government support to increase the manufacturing and usage of 3D medical devices in Asia-Pacific region
- 5.3.3. Advancements, Research and Development, and Investments in 3D Printing for Medical Devices in Europe and Middle East
5.4. Cumulative Impact of Russia-Ukraine Conflict
5.5. Cumulative Impact of High Inflation
5.6. Porter's Five Forces Analysis
- 5.6.1. Threat of New Entrants
- 5.6.2. Threat of Substitutes
- 5.6.3. Bargaining Power of Customers
- 5.6.4. Bargaining Power of Suppliers
- 5.6.5. Industry Rivalry
5.7. Value Chain & Critical Path Analysis
5.8. Regulatory Framework Analysis

6. 3D Printing in Medical Devices Market, by Product Type

6.1. Introduction
6.2. Bone & Cartilage Scaffolds
6.3. Ligament & Tendon Scaffolds
6.4. Prosthetics & Implants
6.5. Surgical Guides
6.6. Surgical Instruments
6.7. Tissue Engineering Products

7. 3D Printing in Medical Devices Market, by Technology

7.1. Introduction
7.2. Droplet Deposition/Extrusion-Based Technologies
7.3. Electron Beam Melting
7.4. Laser Beam Melting
7.5. Photopolymerization

8. 3D Printing in Medical Devices Market, by Component

8.1. Introduction
8.2. Equipment
8.3. Materials
8.4. Services & Software

9. 3D Printing in Medical Devices Market, by End User

9.1. Introduction
9.2. Academic Institutions & Research Laboratories
9.3. Ambulatory Surgical Centers
9.4. Diagnostic Centers
9.5. Hospitals

10. Americas 3D Printing in Medical Devices Market

10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States

11. Asia-Pacific 3D Printing in Medical Devices Market

11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam

12. Europe, Middle East & Africa 3D Printing in Medical Devices Market

12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom

13. Competitive Landscape

13.1. Market Share Analysis, 2023
13.2. FPNV Positioning Matrix, 2023
13.3. Competitive Scenario Analysis
- 13.3.1. restor3d to acquire fellow 3D printed medical device firm Conformis
- 13.3.2. EOS, Tecomet, Precision ADM, and OIC partner to provide end-to-end solution for medical device 3D printing
- 13.3.3. Formlabs Introduces BioMed Durable Resin for Strong, Impact-Resistant Medical Devices
- 13.3.4. Materialise and Vuzix Announce Collaboration to Bring Smart Eyewear to Consumers
- 13.3.5. Zimmer Biomet to acquire medical device company OSSIS
- 13.3.6. Stratasys Completes Acquisition of Covestro's Additive Manufacturing Materials Business
- 13.3.7. Stratasys Signs Agreement with Ricoh USA, Inc. for Print-On-Demand Medical Models
- 13.3.8. Desktop Metal and Henkel announce the onboarding of Loctite branded formulations on the Xtreme 8k machine
- 13.3.9. Stryker Corporation opens new Additive Manufacturing facility in Ireland
- 13.3.10. 9T Labs raises USD 17 million in Series A funding to advance carbon fiber 3D printing

14. Competitive Portfolio

14.1. Key Company Profiles
14.2. Key Product Portfolio